REFERENCES
- Light RW: Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3:75–80.
- Tillett WS, Sherry S: The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations. J Clin Invest. 1949;28:173–190.
- Tillett WS, Sherry S, Read CT: The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. J Thorac Surg. 1951;21:275–297.
- Idell S: Update on the use of fibrinolysins in pleural disease. Clin Pulm Med. 2005;12:184–190.
- Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ: U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352:865–874.
- Sonnappa S, Cohen G, Owens CM, van Doorn C, Cairns J, Stanojevic S, Elliott MJ, Jaffe A: Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med. 2006;174:221–227.
- Idell S, Mazar A, Cines D, Kuo A, Parry G, Gawlak S, Juarez J, Koenig K, Azghani A, Hadden W, McLarty J, Miller E: Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. Am J Respir Crit Care Med. 2002;166:920–926.
- Idell S, Allen T, Chen S, Koenig K, Mazar A, Azghani A: Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol. 2007;292:L25–L32.
- Idell S, Azghani A, Chen S, Koenig K, Mazar A, Kodandapani L, Bdeir K, Cines D, Kulikovskaya I, Allen T: Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits. Exp Lung Res. 2007;33:419–440.
- Zhu Z, Hawthorne ML, Guo Y, Drake W, Bilaceroglu S, Misra HL, Light RW: Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest. 2006;129:1577–1583.
- Sasse SA, Causing LA, Mulligan ME, Light RW: Serial pleural fluid analysis in a new experimental model of empyema. Chest. 1996;109:1043–1048.
- Davies CW, Lok S, Davies RJ: The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med. 1998;157:328–330.
- Gyetko MR, Chen GH, McDonald RA, Goodman R, Huffnagle GB, Wilkinson CC, Fuller JA, Toews GB: Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. J Clin Invest.. 1996;97:1818–1826.
- Gyetko MR, Sitrin RG, Fuller JA, Todd RF, Petty H, Standiford TJ: Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukoc Biol. 1995;58:533–538.
- Gyetko MR, Sud S, Kendall T, Standiford TJ: Urokinase receptor-deficient transgenic mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas infection. Am. J. Respir. Crit. Care Med. 1999;159:A253.
- Abraham E, Gyetko M, Kuhn K, Arcoli J, Strassheim D, Park JS, Shetty S, Idell S: Urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation. J Immunol. 2003;170:5644–5651.
- Idell S, Zwieb C, Kumar A, Koenig KB, Johnson AR: Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol. 1992;7:414–426.
- Passero CJ, Mueller GM, Rondon-Berrios H, Tofovic SP, Hughey RP, Kleyman TR: Plasmin activates epithelial Na+ channels by cleaving the gamma subunit. J Biol Chem. 2008;283:36586–36591.